Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Coronary Angiography Devices Market Poised To Hit $13.83 Billion By 2030 With A 6.6% CAGR#_x000D_
The coronary angiography devices market has experienced robust expansion in recent years. It will grow from $10.03 billion in 2025 to $10.7 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The market’s historical expansion is largely due to factors including the escalating incidence of coronary artery disease, a greater volume of cardiac catheterization procedures, advancements in hospital cardiac care infrastructure, the wider integration of x-ray based angiography systems, and enhanced recognition of heart disease at early stages._x000D_
_x000D_
The coronary angiography devices market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $13.83 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period stems from factors such as an aging demographic prone to elevated cardiovascular risks, a heightened need for prompt and precise coronary diagnostics, the proliferation of interventional cardiology facilities, the increasing embrace of image-guided cardiac interventions, and a growing emphasis on preventive cardiology measures. Key developments expected over this period encompass a surge in the adoption of minimally invasive methods for coronary diagnosis, wider implementation of sophisticated imaging technologies in cardiac assessment, a greater need for highly accurate coronary visualization, an expanding application of angiography for detecting early-stage cardiac conditions, and an increasing convergence of diagnostic and therapeutic angiography processes._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Coronary Angiography Devices Market Growth Factors Behind Sustained Expansion#_x000D_
The expanding occurrence of vascular heart diseases is anticipated to drive the growth of the coronary angiography devices market moving forward. These conditions include disorders that impact the blood vessels providing blood to the heart or those situated within the heart itself. Their heightened prevalence is attributed to evolving lifestyle habits, including diet and physical activity, an aging demographic, and the growing incidence of ailments like diabetes and hypertension. Coronary angiography devices are instrumental in diagnosing and assessing vascular heart diseases by generating detailed images of the coronary arteries, thereby allowing for the accurate identification of blockages, constrictions, and other anomalies that inform treatment choices. For instance, in October 2024, data from the Centers for Disease Control and Prevention, which is a US-based, government agency, indicated that in 2023, cardiovascular disease was responsible for 919,032 lives, making up approximately one in every three deaths. Thus, the expanding prevalence of vascular heart diseases acts as a significant impetus for the coronary angiography devices market._x000D_
_x000D_
#Coronary Angiography Devices Market Segment Performance And Emerging Opportunities#_x000D_
The coronary angiography devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires, Angiography Accessories_x000D_
2) By Technology: X-Ray Angiography, Computed Tomography Angiography (CTA), Magnetic Resonance Angiography, Other Technologies_x000D_
3) By Indication: Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Other Indications_x000D_
4) By Application: Diagnostics, Therapeutics_x000D_
5) By End-User: Hospital And Clinics, Diagnostic And Imaging Centers, Research Institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By Angiography Systems: X-Ray Angiography Systems, 3D Or 4D Angiography Systems, Digital Subtraction Angiography (DSA) Systems _x000D_
2) By Angiography Catheters: Diagnostic Catheters, Therapeutic Catheters, Over-The-Wire (OTW) Catheters, Rapid Exchange (RX) Catheters _x000D_
3) By Angiography Contrast Media: Iodinated Contrast Media, Non-Iodinated Contrast Media _x000D_
4) By Vascular Closure Devices (VCDs): Mechanical VCDs, Passive Hemostasis VCDs, Active Hemostasis VCDs _x000D_
5) By Angiography Balloons: High-Pressure Balloons, Low-Pressure Balloons, Drug-Eluting Balloons _x000D_
6) By Angiography Guidewires: Standard Guidewires, Supportive Guidewires, Steerable Guidewires _x000D_
7) By Angiography Accessories: Introducer Sheaths, Inflation Devices, Syringes And Needles, Guidewire Support Systems_x000D_
_x000D_
#Coronary Angiography Devices Market Industry Trends Fueling Future Revenue Growth#_x000D_
Leading companies active in the coronary angiography devices market are concentrating on developing technological enhancements, such as next-generation drug-eluting stents, to improve procedural exactness, patient outcomes, and enduring cardiovascular health management. Next-generation drug-eluting stents are sophisticated tools engineered with better scaffolding, advanced drug coatings, and superior deliverability to decrease restenosis and promote optimal arterial healing. For example, in May 2024, Abbott Laboratories, a US-based medical devices company, unveiled its XIENCE Sierra stent in India. This stent offers cardiologists enhanced flexibility, accurate placement, and improved safety, aiming to broaden treatment possibilities and raise the standard of care in coronary artery disease management. By integrating innovative design and clinical insights, this launch supports better procedural effectiveness and patient-centric results in interventional cardiology, while also reinforcing Abbott’s commitment to innovation and advancing cardiovascular health across the globe._x000D_
_x000D_
#Coronary Angiography Devices Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the coronary angiography devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., Alvimedica _x000D_
_x000D_
#View The Full Coronary Angiography Devices Market Report:#_x000D_
_x000D_
#Coronary Angiography Devices Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the coronary angiography devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary angiography devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.